As discussed generally for ABC transporters, the inhibition of MRP1 as a MDR-inducing transporter is highly addressed, as the expression of this transporter has been confirmed in various tumor types, mostly of the solid type, and with implications for disease outcome [37]. Here, ABCG2 is linked to neoplasm.